Sirona Biochem to Present at Industry's Premier Conference -- BIO International Convention 2015
Marketwired - Mon May 04, 7:01AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO International, taking place June 15-18 at the Pennsylvania Convention Center, Philadelphia, PA.
SBM.VN: 0.140 (-0.005)
Sirona Biochem Announces Resignation of Board Director
Marketwired - Fri May 01, 8:00PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announced today the resignation of Michael Rogers from the board of directors. Mike served on the board since December 2010.
SBM.VN: 0.140 (-0.005)
Sirona Biochem to Present at BioNetwork East -- May 2015
Marketwired - Mon Apr 13, 7:02AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BioNetwork East on May 4th, 2015 at the Trump International Beach Resort in Miami Florida.
SBM.VN: 0.140 (-0.005)
Sirona Biochem Announces Positive Results With SBM-TFC-837 for Anti-Aging and Regenerative Medicine
Marketwired - Tue Mar 24, 7:02AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) is pleased to announce that its French partner, Biogalenys, observed positive effects of Sirona's glycoprotein SBM-TFC-837 on human fibroblasts in preliminary, in vitro, studies in response to the stressed condition of ultraviolet (UV) radiation.
SBM.VN: 0.140 (-0.005)
Sirona Biochem to Present at BIO Asia 2015 and Received Over $1.1 Million of Warrants Exercised
Marketwired - Thu Mar 12, 1:49PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO Asia, March 24-25, 2015 in Tokyo, Japan. The Company's CSO, Dr. Geraldine Deliencourt-Godefroy, will also be attending.
SBM.VN: 0.140 (-0.005)
Sirona Biochem Announces Successful Development of a Third Skin Lightener With Superior Safety and Efficacy
Marketwired - Wed Mar 11, 3:00AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces the successful development of a third innovative skin-lightening compound that has superior safety, with zero hydroquinone release and 8 times the efficacy of deoxyarbutin. This innovation was made possible through Sirona's platform technology of fluorination chemistry and through support of the European Union and the European Regional Development Fund (E.R.D.F.).
SBM.VN: 0.140 (-0.005)
Sirona Biochem to Present New Results at BIO Europe 2015
Marketwired - Wed Feb 18, 8:02AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO Europe in Paris, France, on March 11th at 11:30AM GMT at the Paris Expo - Porte de Versailles.
SBM.VN: 0.140 (-0.005)
Sirona Biochem Invited to Present at Dose of the Valley Conference, San Francisco
Marketwired - Mon Jan 26, 8:02AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that it has been chosen by the Consulate General of Canada to present at the Dose of the Valley conference on February 3-4 in San Francisco, California.
SBM.VN: 0.140 (-0.005)
Sirona Biochem's Subsidiary TFChem Awarded Prestigious French Innovation Trophy
Marketwired - Tue Dec 02, 6:45AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces that its subsidiary TFChem has been awarded the 6th Haute-Normandie Innovation Trophy from SEINARI -- the Region Haute-Normandie innovation agency. TFChem founder, and Sirona's Chief Scientific Officer, Dr. Géraldine Deliencourt-Godefroy, accepted the award at a ceremony held November 27th in Rouen, France.
SBM.VN: 0.140 (-0.005)
Sirona Biochem Names Attila Hajdu as Chief Business Development Officer
Marketwired - Mon Oct 27, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces that it has named Mr. Attila Hajdu as Chief Business Development Officer. Prior to joining Sirona Biochem, Attila held various senior leadership positions within GlaxoSmithKline (GSK) and Astellas Pharma, accumulating 17 years of experience in Sales, Marketing, R&D Finance, Medical Affairs and Business Development.
SBM.VN: 0.140 (-0.005), GSK: 44.66 (-0.11)